COMPARISON OF EVENT FREE SURVIVAL (EFS) IN HIGH-RISK NEUROBLASTOMA (HRNB) PATIENTS RECEIVING EFLORNITHINE (DFMO) MAINTENANCE TO AN EXTERNAL CONTROL IMMUNOTHERAPY STUDY DATABASE

PEDIATRIC BLOOD & CANCER(2022)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要